UNSPSC 51201652: SARS COV-2 coronavirus vaccine

In November 2021, the WHO licensed the vaccines from Pfizer / BioNTech, AstraZeneca / Oxford, Janssen, Moderna, Sinopharm, Sinovac and Bharat. Other vaccines continue to be studied. Additionally, national regulatory agencies (RNAs) have licensed other COVID-19 vaccines in specific countries.

UNSPSC 51201652 SARS COV-2 coronavirus vaccine is a Commodity code that nominally addresses COVID-19 immunizations, though recent state and local solicitation activity under this code does not reflect that scope. The Mississippi State Department of Health posted a sole source procurement notice on July 13, 2026 for Yellow Fever Vaccine from Sanofi Pasteur, Inc.—a product outside the code's stated vaccine family. The notice invites objections to sole source classification through August 3, 2026 at 10:00 a.m. CST; any entity claiming alternative vendor availability must submit written documentation to the Purchasing Department. If substantiated objections are received, the state will withdraw the sole source notice and conduct an advertised competitive process; if the department determines exclusivity, it will appeal to the Public Procurement Review Board and bear the burden of proof that only Sanofi Pasteur can supply the vaccine. The notice does not specify quantity, contract term, estimated value, or pricing terms.

The available record shows minimal recent activity under this code and a clear mismatch between the code's nominal scope (SARS COV-2 coronavirus vaccine) and the opportunity actually posted (Yellow Fever Vaccine procurement). No recent solicitation activity for COVID-19 vaccines from state or local health departments, school districts, or transit authorities appears in the current dataset. The single recent posting reflects a sole source notice process specific to a named vendor and disease vector unrelated to the code designation, limiting the utility of this code for business development purposes focused on COVID-19 vaccine supply.